The impact of COVID-19 on breast cancer screening, treatment, research and meetings

Bookmark and Share
Published: 5 Oct 2020
Views: 518
Prof David Cameron - Representative EBC Council

Prof David Cameron speaks to ecancer about the EBCC-12 virtual meeting.

Prof Cameron explains some of the challenges to screening, treating and researching breast cancer during the pandemic due to the strain on healthcare resources.

He talks about the importance of the conference at this time, stressing that while there are obvious disadvantages to not being able to meet in person this year there are also advantages to the virtual format. One of the advantages is being able to have a greater reach to low-middle income populations, as while the conference is run from Europe it welcome attendees from around the world.

Prof Cameron concludes by talking about his own sessions from the conference including a debate around breast cancer screening.